On April 3, 2015, Samsung Pharmaceutical Co., Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,292 KRW | +0.62% | -2.56% | -7.91% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
11,300 KRW | +0.89% | -3.67% | 327M | ||
4,455 KRW | +1.37% | +2.06% | 34.57M | ||
1,663 KRW | -1.07% | -2.18% | 115M | ||
1st Jan change | Capi. | |
---|---|---|
-7.91% | 38.67M | |
+17.79% | 3.14B | |
+12.82% | 1.77B | |
+9.53% | 1.5B | |
-11.54% | 1.21B | |
+16.53% | 767M | |
+9.99% | 672M | |
+34.77% | 568M | |
+46.43% | 539M | |
-1.12% | 505M |
- Stock Market
- Equities
- A246690 Stock
- News T.S. Investment Corporation
- Samsung Pharmaceutical Co., Ltd. announced that it has received KRW 15.1 billion in funding from GemVax & Kael Co., Ltd. and other investors.